Anti-CD20-Interferon Alpha Fusion Protein is a promising therapy for NHL patients resistant to standard therapy
Advances in targeted therapies, immunotherapies and epigenetics among highlights
LLS Helps Launch Contest to Honor NBA Legend Kareem Abdul-Jabbar and Raise Awareness of Blood Cancer
If you're a member of the media, please direct all inquiries for The Leukemia & Lymphoma Society's (LLS's) Western & Central New York Chapter to firstname.lastname@example.org or call our Chapter Office at 716.834.2578 or 800.784.2368, ext. 4663.